The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
11
2
2
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Safety Evaluation of Pueraria Lobata Radix in Specific Consumption Scenarios for Type 2 Diabetes
Role: collaborator
Efficacy and Safety of Pueraria Lobata Radix As an Adjuvant Treatment for Type 2 Diabetes Mellitus
Role: collaborator
Clinical Study of Acupuncture Treatment of Knee Osteoarthritis
Role: collaborator
REspiratory diSEAse cohoRt Studies of CHinese Medicine for Asthma (RESEARCH- Asthma)
Role: collaborator
Urgent-start Peritoneal Dialysis in ESRD Patients：A Multi-center Study
Role: collaborator
Multi-center Application of Quantitative FIT Technology in Colorectal Cancer Screening
Role: collaborator
Effect of Electro-acupuncture on Women With Diminished Ovarian Reserve
Role: collaborator
Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Non-organic Gastrointestinal Disorders
Role: collaborator
Fire Needle Therapy on Plaque Psoriasis With Blood Stasis Syndrome
Role: collaborator
Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Stasis Syndrome
Role: collaborator
Chinese Herbal Medicine for Psoriasis Vulgaris: a Real World Study
Role: collaborator
All 11 trials loaded